Your browser doesn't support javascript.
loading
5-HT1A Receptor Agonist Treatment Partially Ameliorates Rett Syndrome Phenotypes in mecp2-Null Mice by Rescuing Impairment of Neuron Transmission and the CREB/BDNF Signaling Pathway.
Dai, Hongmei; Kitami, Yoshikazu; Goto, Yu-Ichi; Itoh, Masayuki.
Affiliation
  • Dai H; Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8551, Japan.
  • Kitami Y; Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8551, Japan.
  • Goto YI; Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8551, Japan.
  • Itoh M; Department of Mental Retardation and Birth Defect Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8551, Japan.
Int J Mol Sci ; 23(22)2022 Nov 14.
Article in En | MEDLINE | ID: mdl-36430502
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rett Syndrome Type of study: Prognostic_studies Limits: Animals Language: En Journal: Int J Mol Sci Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Rett Syndrome Type of study: Prognostic_studies Limits: Animals Language: En Journal: Int J Mol Sci Year: 2022 Document type: Article Affiliation country: Japón Country of publication: Suiza